loadpatents
Patent applications and USPTO patent grants for Targanta Therapeutics, Inc..The latest application filed is for "phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections".
Patent | Date |
---|---|
Phosphonated Rifamycins and uses thereof for the prevention and treatment of bone and joint infections Grant 8,404,664 - Rose , et al. March 26, 2 | 2013-03-26 |
Phosphonated Rifamycins And Uses Thereof For The Prevention And Treatment Of Bone And Joint Infections App 20110263534 - Rose; Yannick Stephane ;   et al. | 2011-10-27 |
Phosphonated Glycopeptide And Lipoglycopeptide Antibiotics And Uses Thereof For The Prevention And Treatment Of Bone And Joint Infections App 20100113333 - Tanaka; Kelly ;   et al. | 2010-05-06 |
Fragments and variants of Staphylococcus aureus DNAG primase, and uses thereof Grant 7,326,541 - Pelletier , et al. February 5, 2 | 2008-02-05 |
DNA sequences from staphylococcus aureus bacteriophage 77 that encode anti-microbial polypeptides Grant 6,982,153 - Pelletier , et al. January 3, 2 | 2006-01-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.